• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Microbot Medical Inc (NQ: MBOT )

    0.9461 -0.0039 (-0.41%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Microbot Medical Inc

    < Previous 1 2 3 4 5 6 Next >
    Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025
    From Microbot Medical Inc.
    Via GlobeNewswire
    Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up
    From Microbot Medical Inc.
    Via GlobeNewswire
    Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System
    Completion of enrollment expected in Q4 with FDA submission for commercialization anticipated by the end of 2024 
    From Microbot Medical Inc.
    Via GlobeNewswire
    Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY® Endovascular Robotic System
    From Microbot Medical Inc.
    Via GlobeNewswire
    MBOT Stock Earnings: Microbot Medical Meets EPS for Q2 2024
    MBOT stock results show that Microbot Medical met analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization
    The ISO 13485 certification is a validation of the Company’s robust quality system 
    From Microbot Medical Inc.
    Via GlobeNewswire
    Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System
    The evaluation phase will explore the potential of integrating robotics, procedure planning and navigation into a single autonomous system 
    From Microbot Medical Inc.
    Via GlobeNewswire
    Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center
    As the third and final clinical site, Memorial Sloan Kettering Cancer Center joins Brigham Women’s Hospital and Baptist Hospital of Miami as sites for the pivotal human clinical trial 
    From Microbot Medical Inc.
    Via GlobeNewswire
    Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial
    From Microbot Medical Inc.
    Via GlobeNewswire
    Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial
    From Microbot Medical Inc.
    Via GlobeNewswire
    Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial
    Following the Company’s recent FDA approval to commence its pivotal human clinical trial, Baptist Hospital of Miami is the second clinical site to enroll in the trial 
    From Microbot Medical Inc.
    Via GlobeNewswire
    Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial
    From Microbot Medical Inc.
    Via GlobeNewswire
    Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial
    The Site Initiation Visit for the BWH clinical staff is complete and a shipment of LIBERTY investigational units was delivered 
    From Microbot Medical Inc.
    Via GlobeNewswire
    Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
    From Microbot Medical Inc.
    Via GlobeNewswire
    Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Why HealthEquity Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Dow Dips Over 300 Points; GameStop Shares Spike Higher
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
    From Microbot Medical Inc.
    Via GlobeNewswire
    Crude Oil Down Over 3%; US Construction Spending Falls In May
    Via Benzinga
    Exposures Fossil Fuels
    Why Microbot Medical Stock Is Up
    Microbot Medical shares are trading higher Monday after the company announced that it has received FDA approval to proceed with its human clinical trial as part of its Investigational Device Exemption... 
    Via Benzinga
    Exposures Product Safety
    Nasdaq Surges 150 Points; US Manufacturing PMI Rises In May
    Via Benzinga
    Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial
    The trial will be conducted in the U.S. and its results will complement the preclinical data on the LIBERTY® Endovascular Robotic Surgical System, which together are expected to support a future 510(k)... 
    From Microbot Medical Inc.
    Via GlobeNewswire
    MBOT Stock Earnings: Microbot Medical Meets EPS for Q1 2024
    MBOT stock results show that Microbot Medical met analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™
    The next step of the collaboration will explore potential future applications of the LIBERTY system, including its potential capabilities for remote endovascular procedures 
    From Microbot Medical Inc.
    Via GlobeNewswire
    Microbot Medical Shares Status Following Recent Geopolitical Events
    From Microbot Medical Inc.
    Via GlobeNewswire
    MBOT Stock Earnings: Microbot Medical Misses EPS for Q4 2023
    MBOT stock results show that Microbot Medical missed analyst estimates for earnings per share the fourth quarter of 2023. 
    Via InvestorPlace
    Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US
    The Investigational Device Exemption (IDE) application follows the completion of multiple activities necessary to file this application 
    From Microbot Medical Inc.
    Via GlobeNewswire
    < Previous 1 2 3 4 5 6 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.